Pfizer beats 3Q net forecasts on lower charges, higher sales

Pfizer beats 3Q net forecasts on lower charges, higher sales


Pfizer doubled its third-quarter profit, on a combination of slightly higher sales, lower one-time charges and reduced spending on production and administration. The drug giant edged past Wall Street's profit expectations and improved its 2017 financial forecast.



from Biotech News
Share:

Комментариев нет:

Отправить комментарий

Pharmacy News Digest

Архив блога